We are live on ! Find out more
Invesco

Invesco Portfolio holdings

AUM $1.02T
1-Year Est. Return 30.18%
 

Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.

This Fund
S&P 500
This Quarter Est. Return
-13.62%
1 Year Est. Return
+30.18%
3 Year Est. Return
+96.06%
5 Year Est. Return
+126.45%
10 Year Est. Return
+482.58%
AUM
$261B
AUM Growth
-$56.5B
Cap. Flow
-$9.3B
Cap. Flow %
-3.56%
Top 10 Hldgs %
16.51%
Holding
3,995
New
135
Increased
1,816
Reduced
1,720
Closed
180

Sector Composition

Rank Sector Weight
1 Technology 18.75%
2 Financials 13.28%
3 Healthcare 12.15%
4 Consumer Discretionary 11.49%
5 Communication Services 9.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MVIS icon
3676
Microvision
MVIS
$84.8M
$14K ﹤0.01%
22,557
-811
-3% -$761
CTIC
3677
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$13K ﹤0.01%
17,276
+27
+0.2% +$44
FBIO icon
3678
Fortress Biotech
FBIO
$111M
$12K ﹤0.01%
930
+60
+7% +$1K
CLSD
3679
DELISTED
Clearside Biomedical
CLSD
$11K ﹤0.01%
+713
New +$33.5K
PLX icon
3680
Protalix BioTherapeutics
PLX
$183M
$11K ﹤0.01%
3,596
-133
-4% -$632
ALIM
3681
DELISTED
Alimera Sciences
ALIM
$11K ﹤0.01%
1,008
+111
+12% +$1.62K
VGZ icon
3682
Vista Gold
VGZ
$250M
$10K ﹤0.01%
19,174
-326
-2% -$167
CGRN
3683
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
$10K ﹤0.01%
1,658
+31
+2% +$244
RGSE
3684
DELISTED
Real Goods Solar, Inc. Class A
RGSE
$10K ﹤0.01%
18,683
-7,494
-29% -$3.48K
UQM
3685
DELISTED
UQM Technologies, Inc.
UQM
$9K ﹤0.01%
10,782
-374
-3% -$447
UAMY icon
3686
United States Antimony
UAMY
$728M
$8K ﹤0.01%
13,063
-470
-3% -$318
WYY icon
3687
WidePoint Corp
WYY
$97.4M
$8K ﹤0.01%
2,030
-98
-5% -$467
TRVN
3688
DELISTED
Trevena, Inc.
TRVN
$8K ﹤0.01%
30
+5
+20% +$2.82K
ZN
3689
DELISTED
Zion Oil & Gas, Inc.
ZN
$8K ﹤0.01%
20,051
-171
-0.8% -$148
TRNX
3690
DELISTED
Taronis Technologies, Inc. Common Stock
TRNX
$8K ﹤0.01%
+334
New +$9.36K
ONCS
3691
DELISTED
OncoSec Medical Incorporated
ONCS
$8K ﹤0.01%
60
+2
+3% +$502
MMAT
3692
DELISTED
Meta Materials Inc. Common Stock
MMAT
$7K ﹤0.01%
64
-3
-4% -$454
SCYX icon
3693
SCYNEXIS
SCYX
$37.4M
$6K ﹤0.01%
146
-4
-3% -$271
IMBI
3694
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
$6K ﹤0.01%
1,480
+52
+4% +$474
VLRX
3695
DELISTED
VALERITAS HOLDINGS INC
VLRX
$6K ﹤0.01%
+969
New +$15.6K
CATX icon
3696
Perspective Therapeutics
CATX
$327M
$5K ﹤0.01%
1,632
-93
-5% -$398
CFMS
3697
DELISTED
Conformis, Inc. Common Stock
CFMS
$5K ﹤0.01%
583
-10
-2% -$168
TMBR
3698
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
$5K ﹤0.01%
3
GMO
3699
DELISTED
General Moly, Inc.
GMO
$5K ﹤0.01%
21,600
+1,680
+8% +$383
SGYP
3700
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$5K ﹤0.01%
+42,461
New +$27.9K

Similar funds

Invesco's Q4 2018 Portfolio in Review

As of Q4 2018, Invesco held 3,995 positions worth $261B, down 18% from $318B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Invesco withdrew a net $9.3B in Q4 2018, closing 180 positions and reducing 1,720 holdings. Its most notable exit was Express Scripts Holding Company, an estimated $691M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Invesco opened a new position in Linde worth $106M.

  • Invesco's largest Q4 2018 buy was Linde: 679,076 shares worth $106M.
  • Invesco added most to NXP Semiconductors in Q4 2018, an estimated $253M increase.
  • Invesco's biggest Q4 2018 reduction was Apple, cutting an estimated $961M.
  • Invesco fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $691M.
  • Invesco's ten largest holdings make up 17% of its $261B portfolio in Q4 2018.
  • Invesco opened 135 new positions and closed 180 in Q4 2018.
  • Invesco's portfolio value fell 18% quarter-over-quarter to $261B.

Based on Invesco's 13F filing for Q4 2018, filed 14 Feb 2019.